Get Started
Home
Topics
Search
Library
Research questionHow can drug–target interaction models preserve weak binding-relevant biochemical patterns across molecular scales?Drug–target interaction models aggregate information from drugs and proteins at multiple biochemical scales. Dominant patterns can overwhelm weaker functional-group and residue-context signals that still influence binding, making relevant cross-entity correspondences difficult to learn.
AI
Health
Machine Learning
Research Paper
Latest papersRecent research connected to this question, newest first.ProbeMatchDTI: Probe-Driven Multi-Scale Biochemical Pattern Matching for Drug-Target Interaction PredictionThe source studies ProbeMatchDTI for drug–target interaction prediction, with evaluations on BindingDB and DrugBank. It also reports feature-level pattern analyses and connects predictions to candidate refinement and validation planning; the evidence does not establish experimental or clinical effectiveness.research paper · Sep 2, 2026
Related questions
How can we rapidly generate and complete 3D molecules conditioned on protein binding pockets?How can molecular property predictors retain substructure and graph-distance information in compact representations without external pretraining?How can protein language models predict mutation effects accurately without the cost of larger dense models?How can structure-based lead optimization improve target affinity without increasing off-target binding when off-target structures are unknown?